COVID-19

A new webinar series from the National Academy of Medicine (NAM) and the American Society of Addiction Medicine (ASAM) providing insight and targeted guidance on how to ensure that people with addiction are cared for and protected during the COVID-19 public health crisis.

This document provides a directory of mobile applications (apps) that may be used as aids in mental health or addiction conditions.

Provides guidance to addiction treatment clinicians and programs on the regulatory and general practice issues related to the use of telehealth during the COVID-19 national emergency.

A comprehensive household interview survey of substance use, substance use disorders, mental health, and the receipt of treatment services for these disorders in the United States.

A Protocol using empirically-supported behavioral treatments for people with psychoactive stimulant use disorders. There are manuals for healthcare professionals who provide treatment services for individuals with psychoactive substance use disorder (PSUD) and for patients who are entering PSUD treatment.

This brief explores COVID-19 policy changes related to access to medications for opioid use disorder and recommends changes to keep in place beyond the emergency period.

This page is designed for people who use drugs or have substance use disorder; their friends, family, and loved ones; and the general public.

This list provides information on the U.S. states and territories modifying requirements for telehealth in response to COVID-19, including out-of-state physicians, preexisting provider-patient relationships; and audio-only requirements.

This list provides information on U.S. states and territories telehealth waivers.

This list provides information on the U.S. states and territories modifying licensure requirements for physicians in response to COVID-19, including out-of-state physicians in-person practice and license renewals.